The following priorities for Launch Pilot grants will be articulated to the review committee:

• Applications that have been favorably reviewed extramurally and/or by the WVCTSI that are re- submitted with clear responsiveness to previous critique and a plan for translational focus of the research.
• Proposals with investigator teams that include clinician scientists in key roles (PI/Co-PI) with clearly articulated plans for translational application of the research. Clinician investigators must contribute an appropriate amount of effort (minimum 10% effort for the PI) to the project and their roles must be clearly defined in the application.
• Proposals with strong potential to secure external funding; this potential will be evaluated based on the science as well as the PI (if single PI) or the team of investigators if Co-investigators are included in the application.
• WVCTSI thematic focus topics related to Addiction, Alzheimer’s Disease, emerging epidemics (e.g., SARS-CoV-2, HIV, Hepatitis C), Cancer, Cardiovascular Disease (including stroke), Chronic Lung Disease and the risk factors associated with the aforementioned thematic focus topics.
• Applications intended to stimulate innovation and commercialization.